Question explored with the scientific record
Is it worth getting the flu jab
The short version: the flu shot probably reduces your risk of dying from any cause by a modest amount, but the evidence is weaker than you have been told, and the question is whether that benefit is worth the injection for you.
The evidence here is almost entirely observational, not from randomized trials. That matters because people who get flu shots are also more likely to take care of their health in other ways. The best study in this set that tried to correct for that bias found a 4.6% reduction in all-cause mortality during flu season among elderly Kaiser Permanente members [4]. That is a small effect, not the dramatic 50% reductions that unadjusted studies often report.
The strongest evidence for benefit comes from specific high-risk groups. A meta-analysis of six observational studies in people with diabetes found that flu vaccination was associated with about a 46% lower odds of death [1]. A large Australian study of pregnant women found that maternal vaccination was associated with a 34% lower risk of infant death in the first year of life [2]. A cluster-randomized trial in UK care homes found that vaccinating staff reduced resident deaths by about 5 per 100 during flu season [3]. These are real signals, but they come from populations that are already vulnerable.
The risk of serious harm is low but not zero. The 1976 swine flu vaccine caused about 10 extra cases of Guillain-Barré syndrome per million doses [7]. For modern flu vaccines, the risk is smaller: about 1 extra case per million doses [5, 6]. That is a real risk, but it is very small compared to the background rate of GBS from infections themselves.
What the evidence does not answer is whether a healthy adult or child benefits from annual flu shots. The studies that show the largest effects are in the elderly, the chronically ill, and institutionalized populations. For a healthy person, the absolute risk of dying from flu is already very low, and the vaccine's marginal benefit shrinks accordingly. The Cochrane reviews (not in this retrieval but well-documented) have consistently found that flu vaccines in healthy adults prevent about one case of lab-confirmed flu per 40 vaccinated, but do not clearly reduce hospitalization or death.
| Population | Outcome | Effect | Source |
|---|---|---|---|
| Elderly (65+) | All-cause mortality during flu season | 4.6% relative reduction | [4] |
| People with diabetes | All-cause mortality | ~46% lower odds | [1] |
| Care home residents (via staff vaccination) | All-cause mortality during flu season | 5 fewer deaths per 100 residents | [3] |
| Infants (via maternal vaccination) | All-cause mortality in first year | 34% lower risk | [2] |
| General population | Guillain-Barré syndrome | ~1 extra case per million doses | [5, 6] |
My call: for an elderly person or someone with chronic illness, the flu shot is probably worth it, though the benefit is smaller than advertised. For a healthy adult or child, the benefit is marginal and the decision should be personal, not mandated. Confidence: moderate for high-risk groups, low for healthy individuals.
Sources used 7
-
Impact of Influenza Vaccination on All-Cause Mortality and Hospitalization for Pneumonia in Adults and the Elderly with Diabetes: A Meta-Analysis of Observational Studies
A meta-analysis of six observational studies found that influenza vaccination in adults and elderly people with diabetes was associated with lower all-cause mortality (MH-OR 0.54, 95% CI 0.40-0.74) and lower hospitalization for pneumonia (MH-OR 0.89, 95% CI 0.80-0.98).
DOI: 10.3390/vaccines8020263 -
Neonatal and infant mortality after maternal influenza and pertussis vaccination: Probabilistically linked cohort study
A large population-based cohort in three Australian jurisdictions linked maternal vaccination data with infant outcomes to evaluate whether in-pregnancy influenza and/or pertussis vaccination affects neonatal and infant mortality, finding reduced all-cause infant mortality with …
DOI: 10.1080/21645515.2025.2587307 -
Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial
A cluster-randomised trial in UK care homes found that vaccinating care home staff against influenza reduced resident mortality, influenza-like illness, GP consultations for influenza-like illness, and hospital admissions during periods of influenza activity in the 2003-04 seaso…
DOI: 10.1136/bmj.39010.581354.55 -
Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias
This study investigates the impact of influenza vaccination on mortality among elderly members of Kaiser Permanente in Northern California, revealing a vaccine effectiveness of 4.6% during flu seasons while addressing potential biases in previous observational studies.
DOI: 10.1093/aje/kwp173 -
The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
In four U.S. states during the 1992-1994 influenza seasons, this population-based study estimated the risk of Guillain-Barré syndrome after influenza vaccination, finding a small, adjusted increase (about 1.7-fold) with roughly one additional case per million vaccinations, indic…
DOI: 10.1056/NEJM199812173392501 -
The Risk of Guillain–Barré Syndrome Associated with Influenza A (H1N1) 2009 Monovalent Vaccine and 2009–2010 Seasonal Influenza Vaccines: Results from Self‐Controlled Analyses
Self-controlled analyses of vaccinated GBS cases found a small, measurable excess of Guillain-Barré syndrome in the 42 days after 2009 H1N1 vaccination (variable-window RR 2.1, fixed-window RR 3.0; about 1.5-2.8 attributable cases per million doses), with absolute risk not clear…
DOI: 10.1002/pds.3220 -
Guillain-Barré Syndrome and Vaccination: Usually Unrelated
A narrative review of epidemiological data on Guillain-Barré syndrome (GBS) and vaccines concludes that GBS is usually triggered by antecedent infections rather than vaccination; clear causal associations were limited to the obsolete neural-tissue rabies vaccine and the 1976 swi…
DOI: 10.1177/001857870003500214